Matterworks

Website: www.matterworks.ai

Biology has always been an empirical science. We're making it a science of prediction.

Matterworks builds foundation models for biochemical omics — the next frontier in AI-powered research. Our platform, Pyxis, applies large-scale spectral modeling to mass spectrometry data, giving pharma and biotech teams the power to predict biological properties, classify disease states, and anticipate outcomes across the entire R&D lifecycle. From self-service exploration to lab services and enterprise partnerships, we work with pharma and biotech organizations to bring predictive biology to every stage of R&D.

Solix Technologies

Website: www.solix.com/solutions/solix-eai-pharma

Solix powers AI-driven drug discovery with a platform built for the real data challenges of pharma and biotech. From early research to clinical execution, we unify siloed data, apply scalable AI and automation, and enable governed, audit-ready intelligence that accelerates therapeutic programs. Our semantic data layer, cloud-native architecture, and purpose-built life sciences apps reduce time-to-insight, improve reproducibility, and future-proof compliance, without forcing teams to “rip and replace” existing systems. With 20+ years in industry, 100+ petabytes of scientific and clinical data processed, and deployments across leading biopharma, Solix enables organizations to move faster, collaborate better, and compete with confidence in a world where data is the molecule.

MilliporeSigma

Website: www.sigmaaldrich.com

Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. 

We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. 

Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come.

The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries.